API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
73
PharmaCompass offers a list of Tenoxicam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tenoxicam manufacturer or Tenoxicam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tenoxicam manufacturer or Tenoxicam supplier.
PharmaCompass also assists you with knowing the Tenoxicam API Price utilized in the formulation of products. Tenoxicam API Price is not always fixed or binding as the Tenoxicam Price is obtained through a variety of data sources. The Tenoxicam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tenoxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenoxicam, including repackagers and relabelers. The FDA regulates Tenoxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenoxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tenoxicam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tenoxicam supplier is an individual or a company that provides Tenoxicam active pharmaceutical ingredient (API) or Tenoxicam finished formulations upon request. The Tenoxicam suppliers may include Tenoxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Tenoxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tenoxicam CEP of the European Pharmacopoeia monograph is often referred to as a Tenoxicam Certificate of Suitability (COS). The purpose of a Tenoxicam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tenoxicam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tenoxicam to their clients by showing that a Tenoxicam CEP has been issued for it. The manufacturer submits a Tenoxicam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tenoxicam CEP holder for the record. Additionally, the data presented in the Tenoxicam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tenoxicam DMF.
A Tenoxicam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tenoxicam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tenoxicam suppliers with CEP (COS) on PharmaCompass.
A Tenoxicam written confirmation (Tenoxicam WC) is an official document issued by a regulatory agency to a Tenoxicam manufacturer, verifying that the manufacturing facility of a Tenoxicam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tenoxicam APIs or Tenoxicam finished pharmaceutical products to another nation, regulatory agencies frequently require a Tenoxicam WC (written confirmation) as part of the regulatory process.
click here to find a list of Tenoxicam suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tenoxicam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tenoxicam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tenoxicam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tenoxicam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tenoxicam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tenoxicam suppliers with NDC on PharmaCompass.
Tenoxicam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tenoxicam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tenoxicam GMP manufacturer or Tenoxicam GMP API supplier for your needs.
A Tenoxicam CoA (Certificate of Analysis) is a formal document that attests to Tenoxicam's compliance with Tenoxicam specifications and serves as a tool for batch-level quality control.
Tenoxicam CoA mostly includes findings from lab analyses of a specific batch. For each Tenoxicam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tenoxicam may be tested according to a variety of international standards, such as European Pharmacopoeia (Tenoxicam EP), Tenoxicam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tenoxicam USP).